Adverse Drug Event Reporting

2012 ◽  
Vol 31 (8) ◽  
pp. 1911-1911
Author(s):  
William Vaughan
Keyword(s):  
Adverse Drug Event ◽  
Drug Event ◽  
Event Reporting

Secondary use of electronic health record data: spontaneous triggered adverse drug event reporting

2010 ◽  
Vol 19 (12) ◽  
pp. 1211-1215 ◽  
Author(s):  
Jeffrey A. Linder ◽  
Jennifer S. Haas ◽  
Aarthi Iyer ◽  
Michael A. Labuzetta ◽  
Michael Ibara ◽  
...  
Keyword(s):  
Electronic Health Record ◽  
Adverse Drug Event ◽  
Drug Event ◽  
Health Record ◽  
Electronic Health Record Data ◽  
Event Reporting ◽  
Secondary Use ◽  
Record Data ◽  
Electronic Health

Impact of nurse case manager-pharmacist collaboration on adverse-drug-event reporting

2004 ◽  
Vol 61 (5) ◽  
pp. 483-487 ◽  
Author(s):  
Paul F. Lata ◽  
Marianne Mainhardt ◽  
Curtis A. Johnson
Keyword(s):  
Adverse Drug Event ◽  
Case Manager ◽  
Drug Event ◽  
Event Reporting ◽  
Nurse Case Manager

scholarly journals Adverse drug event reporting systems: a systematic review

2016 ◽  
Vol 82 (1) ◽  
pp. 17-29 ◽  
Author(s):  
Chantelle Bailey ◽  
David Peddie ◽  
Maeve E. Wickham ◽  
Katherin Badke ◽  
Serena S. Small ◽  
...  
Keyword(s):  
Systematic Review ◽  
Adverse Drug Event ◽  
Drug Event ◽  
Event Reporting ◽  
Reporting Systems

scholarly journals Adverse Drug Event Reporting From Clinical Care: Mixed-Methods Analysis for a Minimum Required Dataset (Preprint)

2018 ◽  
Author(s):  
David Peddie ◽  
Serena S Small ◽  
Katherin Badke ◽  
Chantelle Bailey ◽  
Ellen Balka ◽  
...  
Keyword(s):  
Systematic Review ◽  
Patient Safety ◽  
Mixed Methods ◽  
Adverse Drug Event ◽  
Improve Patient Safety ◽  
Clinical Care ◽  
Drug Event ◽  
Care Providers ◽  
Event Reporting ◽  
Improve Patient

BACKGROUND Patients commonly transition between health care settings, requiring care providers to transfer medication utilization information. Yet, information sharing about adverse drug events (ADEs) remains nonstandardized. OBJECTIVE The objective of our study was to describe a minimum required dataset for clinicians to document and communicate ADEs to support clinical decision making and improve patient safety. METHODS We used mixed-methods analysis to design a minimum required dataset for ADE documentation and communication. First, we completed a systematic review of the existing ADE reporting systems. After synthesizing reporting concepts and data fields, we conducted fieldwork to inform the design of a preliminary reporting form. We presented this information to clinician end-user groups to establish a recommended dataset. Finally, we pilot-tested and refined the dataset in a paper-based format. RESULTS We evaluated a total of 1782 unique data fields identified in our systematic review that describe the reporter, patient, ADE, and suspect and concomitant drugs. Of these, clinicians requested that 26 data fields be integrated into the dataset. Avoiding the need to report information already available electronically, reliance on prospective rather than retrospective causality assessments, and omitting fields deemed irrelevant to clinical care were key considerations. CONCLUSIONS By attending to the information needs of clinicians, we developed a standardized dataset for adverse drug event reporting. This dataset can be used to support communication between care providers and integrated into electronic systems to improve patient safety. If anonymized, these standardized data may be used for enhanced pharmacovigilance and research activities.

scholarly journals Pharmacovigilance evaluation of the relationship between impaired glucose metabolism and BCR-ABL inhibitor use by using an adverse drug event reporting database

2018 ◽  
Vol 8 (1) ◽  
pp. 174-181 ◽  
Author(s):  
Naoto Okada ◽  
Takahiro Niimura ◽  
Yoshito Zamami ◽  
Hirofumi Hamano ◽  
Shunsuke Ishida ◽  
...  
Keyword(s):  
Glucose Metabolism ◽  
Adverse Drug Event ◽  
Drug Event ◽  
Impaired Glucose Metabolism ◽  
Event Reporting ◽  
The Relationship
Sign in / Sign up

Export Citation Format

Share Document